ANGION BIOMEDICA TO PRESENT AT PIPER JAFFRAY HEALTHCARE CONFERENCE

 

UNIONDALE, N.Y. November 12th, 2018 – (PRNewswire)  – Angion Biomedica, a late-stage biotechnology company that is developing novel treatments for acute and chronic organ injury, today announced that Jay Venkatesan, M.D., chief executive officer, will present a corporate overview at the 30th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 27th, 2019.

 

About Angion

Angion Biomedica Corp. is a biopharmaceutical company discovering and developing novel therapeutic agents for acute and chronic organ diseases and disorders. Angion’s programs are currently focused on renal transplantation, AKI, and chronic kidney disease, with a pipeline of additional indications and product candidates. For further information, please visit www.angion.com. 


Angion Biomedica
Elisha Goldberg
Director, Business Development
917-420-0666
egoldberg@angion.com